Verastem (NASDAQ: VSTM) updates investor corporate presentation on website

Rhea-AI Filing Summary

Verastem, Inc. filed a current report to inform investors that it has posted an updated corporate presentation on its website. The updated presentation, dated January 8, 2026, is also included as Exhibit 99.1.

This type of disclosure is meant to provide the market with the same information that the company is sharing in its investor materials, helping ensure all investors have equal access to the updated corporate overview and strategy details.

false 0001526119 0001526119 2026-01-08 2026-01-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): January 8, 2026

Verastem, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware		001-35403		27-3269467
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

117 Kendrick Street, Suite 500, Needham, MA		02494
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code: (781) 292-4200

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.0001 par value per share		VSTM		The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 7.01 Regulation FD Disclosure

On January 8, 2026, Verastem, Inc. posted its updated corporate presentation on its website, a copy of which is furnished hereto as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits

Exhibit No.		Description
99.1		Corporate Presentation, dated January 8, 2026
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	VERASTEM, INC.
Dated: January 8, 2026	By:	/s/ Daniel W. Paterson
		Daniel W. Paterson
		Chief Executive Officer

FAQ

What did Verastem (VSTM) disclose in this 8-K?

Verastem disclosed that it posted an updated corporate presentation on its website, which is furnished as Exhibit 99.1 dated January 8, 2026.

Which SEC item does this Verastem (VSTM) 8-K relate to?

The report is filed under Item 7.01 Regulation FD Disclosure, covering the public posting of Verastem's updated corporate presentation.

What exhibit is included with Verastem’s updated presentation?

The updated corporate presentation is included as Exhibit 99.1, titled "Corporate Presentation, dated January 8, 2026."

Does this Verastem (VSTM) 8-K announce any major transaction or earnings results?

No, this 8-K focuses on the Regulation FD disclosure of an updated corporate presentation and does not describe major transactions or earnings data.

Who signed this Verastem (VSTM) current report?

The report was signed on behalf of Verastem, Inc. by Daniel W. Paterson, the company’s Chief Executive Officer.

Where is Verastem’s common stock listed and under what symbol?

Verastem’s common stock is listed on The Nasdaq Capital Market under the trading symbol VSTM.